During the second quarter, guru Jean Hynes reduced her stake in Actelion (XSWX:ATLN)Â at an average price of 155.36 Swiss francs ($160). The trade had a 0.13% impact on Hynes' portfolio. She now owns 2,233,722 shares of the company.
Actelion was founded on December 17, 1997. The company specializes in human biology and  engages in the discovery, development and commercialization of drugs for diseases with unmet medical needs. The company's products include Opsumit, which is an oral medication used to treat pulmonary arterial hypertension; Tracleer, a prescription medicine indicated for patients with certain types of pulmonary arterial hypertension, which is high blood pressure in the vessels of the lungs; Uptravi, an approved oral, selective IP receptor agonist targeting the prostacyclin pathway in PAH; Veletri, a prescription medicine that is given intravenously, which is used to treat adults with certain kinds of severe pulmonary arterial hypertension; Ventavis, an inhalation solution used to treat adults with certain kinds of severe pulmonary arterial hypertension, a condition in which blood pressure is too high in the blood vessels between the heart and the lungs.
Actelion has a market cap of 17.54 billion Swiss francs, an enterprise value of 17.12 billion Swiss francs, a price-earnings ratio of 30.66 and a price-book ratio of 18.94.
According to GuruFocus, Actelion has a 9 of 10 financial rating, with no debt. The company also has an 8 of10 profitability and growth rating, with an operating margin of 32.71%, ranking it above 93% of the 733 companies in the global biotechnology industry.
It is likely that Hynes decided to reduce her stake in Actelion because the company reached its 10-year high in price during the second quarter. Since Hynes reduced her stake in Actelion, the company share price has risen an estimated 7%.
Below, the Peter Lynch chart shows that Actelion is trading above its intrinsic value.
The Vanguard Health Care Fund was originally founded by Ed Owens in 1984. The fund returned an average of 16% per year while Owens ran the fund. Hynes spent 20 years working alongside Owens before she began co-managing the fund in 2008. Ed Owens retired in 2012 and since then, Jean Hynes has been running the Vanguard Health Care Fund. Since the Vanguard Health Care Fund's inception, it has returned an estimated 17.4% annually.
Cheers to your investment success
Disclosure: Author does not own any shares of this company.
Start a free 7-day trial of Premium Membership to GuruFocus.
